India’s drug regulator will approve a coronavirus vaccine developed by the University of Oxford and AstraZeneca on Friday for emergency use, according to the news agency. Reuters reported. The expert committee set up by Comptroller General of Drugs of India (DCGI) VG Somani to examine vaccine proposals, meeting for the …
Read More »Covid-19 Vaccine Updates: India Likely Decides On First Vaccine This Week, South Korea Seeks Moderna Candidate
Vaccines against the coronavirus disease (Covid-19) are currently underway in many countries and several others are also preparing to start their immunization campaigns. So far, most countries have granted Emergency Use Authorization (EUA) to the Pfizer Inc-BioNTech SE or Moderna vaccine candidate, or both. Meanwhile, several other candidates, such as …
Read More »Ahmedabad begins online registration. Who can do it?
A ‘safe and effective’ vaccine against the new coronavirus could soon become a reality. India has already started the registration process to distribute the vaccine as soon as it is available. Ahmedabad Municipal Corporation launched an online portal for vaccination registration on Saturday, news agency PTI reported. The coronavirus vaccine …
Read More »Pfizer partner BioNTech ‘can make a vaccine in 6 weeks if needed’
The German pharmaceutical company BioNTech is confident that its coronavirus vaccine will work against the mutated strain detected in Britain. “Scientifically, it is very likely that the immune response of this vaccine can also cope with the new virus variant,” said Ugur Sahin, co-founder of BioNTech. However, “we do not …
Read More »Modern to start dosing tomorrow; Oxford will get UK approval next week
Written by Abhishek De | New Delhi | Updated: December 20, 2020 7:47:28 pm Swab collection for ongoing Covid-19 testing inside an NMMC mobile testing facility in Vashi (Express photo by Amit Chakravarty) The United States was shot in the arm in its fight against Covid-19 after the Food and …
Read More »Guidelines Enrollment Details Explained
A ‘safe and effective’ vaccine against the new coronavirus will soon become a reality in India. Pfizer, Serum Institute of India and Bharat Biotech have applied for marketing authorization for their vaccines. The vaccination campaign will begin once the country approves the emergency use of any of the candidate vaccines. …
Read More »Covid-19 Vaccine Update: Gennova Pharmaceuticals Gets Permission for Trials, US Considers Moderna Candidate Safe for Use
The global search for a vaccine to treat the coronavirus disease (Covid-19) has entered a crucial phase with at least three countries – the United Kingdom, the United States and Canada – beginning to administer vaccines for emergencies. These are shots of the Pfizer Inc-BioNTech SE candidate vaccine, which has …
Read More »30 cr to receive the dose in Phase I; pre-registration; photo ID must
India has published detailed guidelines for the massive COVID-19 vaccination campaign that will start soon. The central government plans to vaccinate nearly 30 million people during the first vaccination phase. Pfizer, Serum Institute of India and Bharat Biotech have applied for marketing authorization for their vaccines. The vaccination campaign will …
Read More »Serum Institute will produce 10 crore doses every month starting next year
The Serum Institute of India plans to make up to 10 crore doses of coronavirus vaccine each month, starting next year, said CEO Adar Poonawalla. The Pune-based drug maker has partnered with global pharmaceutical giant AstraZeneca to produce the COVID-19 vaccine for the University of Oxford for low- and middle-income …
Read More »Covid-19 vaccine update: Bahrain gives Pfizer a go-ahead, India purchase will cover 60% of population, Moscow begins mass vaccination
After the UK agreed to the emergency use of the Pfizer vaccine, the global race to vaccinate people has grown more intense. After the UK, Bahrain has become the second nation in the world to grant an emergency authorization for the Pfizer-BioNTech vaccine. Meanwhile, the World Health Organization has warned …
Read More »